SCHEMBL8069022

SCHEMBL8069022

COc1ccc(-c2cc(=O)c3c(O)c(OC)c(O)cc3o2)cc1O

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 4/20 0.86
CYP1A1 P04798 4/20 0.86
CYP1B1 Q16678 4/20 0.86
HDAC6 Q9UBN7 2/20 0.86
AURKA O14965 1/20 0.86
KDR P35968 1/20 0.86
AURKB Q96GD4 1/20 0.86
HSD17B2 P37059 1/20 0.82
TAS2R31 P59538 1/20 0.82
POLB P06746 4/20 0.82
MAPT P10636 4/20 0.82
MEN1 O00255 3/20 0.82
NPC1 O15118 3/20 0.82
KMT2A Q03164 3/20 0.82
GFER P55789 2/20 0.82
KDM4E B2RXH2 2/20 0.82
AMY1A P0DUB6 1/20 0.82
GAA P10253 1/20 0.82
THRB P10828 1/20 0.82
APEX1 P27695 1/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30799172 1.00 FLT3 (0.86) FLT3CYP1A1CYP1B1HDAC6AURKA
Eupatilin SCHEMBL29568655 0.93 HDAC6 (1.00) FLT3CYP1A1CYP1B1HDAC6AURKA
Eupatilin SCHEMBL1033509 0.93 HDAC6 (1.00) FLT3CYP1A1CYP1B1HDAC6AURKA
Eupatilin SCHEMBL29926197 0.93 HDAC6 (1.00) FLT3CYP1A1CYP1B1HDAC6AURKA
Eupatorin SCHEMBL29386042 0.93 CYP1A1 (1.00) FLT3CYP1A1CYP1B1HDAC6AURKA
Eupatorin SCHEMBL30334912 0.93 CYP1A1 (1.00) FLT3CYP1A1CYP1B1HDAC6AURKA
Eupatorin SCHEMBL555597 0.93 CYP1A1 (1.00) FLT3CYP1A1CYP1B1HDAC6AURKA
SCHEMBL8062995 0.91 CYP1A1 (0.88) FLT3CYP1A1CYP1B1HDAC6AURKA
Jaceosidine SCHEMBL29926544 0.90 HSD17B2 (1.00) FLT3CYP1A1CYP1B1HDAC6AURKA
Jaceosidine SCHEMBL3960077 0.90 HSD17B2 (1.00) FLT3CYP1A1CYP1B1HDAC6AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120029066-A1 USE OF FLAVONES FOR TREATING PSYCHIATRIC DISORDERS WITH SENSORIMOTOR GATING DEFICITS TAIPEI MEDICAL UNIVERSITY (TW) 2012-02-02 US disclosed
US-6025387-A Gastroprotective flavone/flavanone compounds with therapeutic effect on inflammatory bowel disease DONG A PHARMACEUTICAL CO., LTD. (KR) 2000-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120029066-A1 USE OF FLAVONES FOR TREATING PSYCHIATRIC DISORDERS WITH SENSORIMOTOR GATING DEFICITS HTR2C, GRIN2C, HTR5A FLT3 3391/4885CYP1A1 416/4885CYP1B1 1037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.